What Has 30 Years of HIV Vaccine Research Taught Us?

Vaccines
José Esparza

Abstract

When HIV was discovered and established as the cause of AIDS in 1983-1984, many people believed that a vaccine would be rapidly developed. However, 30 years have passed and we are still struggling to develop an elusive vaccine. In trying to achieve that goal, different scientific paradigms have been explored. Although major progress has been made in understanding the scientific basis for HIV vaccine development, efficacy trials have been critical in moving the field forward. Major lessons learned are: the development of an HIV vaccine is an extremely difficult challenge; the temptation of just following the fashion should be avoided; clinical trials are critical, especially large-scale efficacy trials; HIV vaccine research will require long-term commitment; and sustainable collaborations are needed to accelerate the development of an HIV vaccine. Concrete actions must be implemented with the sense of urgency imposed by the severity of the AIDS epidemic.

References

Oct 12, 1991·BMJ : British Medical Journal·R Weiss
Apr 2, 1987·Nature·R C Gallo, L Montagnier
Mar 19, 1987·Nature·D ZaguryW Justin
Sep 18, 1987·JAMA : the Journal of the American Medical Association·B Merz
May 20, 1994·Science·J Cohen
May 23, 1997·Science·A Lawler, J Cohen
Jan 24, 1998·Nature·E A BergerR A Weiss
May 11, 2002·Nature Reviews. Immunology·Andrew McMichael, Tomâs Hanke
Jun 28, 2003·Science·Richard D KlausnerJudith N Wasserheit
Feb 3, 2005·The Journal of Infectious Diseases·Neil M FlynnUNKNOWN rgp120 HIV Vaccine Study Group
Mar 12, 2005·Human Gene Therapy·Dan H Barouch, Gary J Nabel
Nov 17, 2006·The Journal of Infectious Diseases·Punnee PitisuttithumUNKNOWN Bangkok Vaccine Evaluation Group
Apr 11, 2007·The Journal of Experimental Medicine·José Esparza, Tadataka Yamada
May 18, 2007·The New England Journal of Medicine·Margaret I Johnston, Anthony S Fauci
Dec 7, 2007·PLoS Medicine·David MontefioriUNKNOWN Working Group convened by the Global HIV Vaccine Enterprise
Jul 26, 2008·Science·Anthony S FauciWarner C Greene
Oct 22, 2009·The New England Journal of Medicine·Supachai Rerks-NgarmUNKNOWN MOPH-TAVEG Investigators
May 14, 2010·Clinical and Vaccine Immunology : CVI·Stanley A Plotkin
Jun 1, 2010·Vaccine·Punnee PitisuttithumSupachai Rerk-Ngnam
Sep 29, 2011·Annual Review of Medicine·Louis J PickerJeffrey D Lifson
Apr 6, 2012·The New England Journal of Medicine·Barton F HaynesJerome H Kim
May 9, 2012·Nature Biotechnology·Barton F HaynesThomas B Kepler
Sep 14, 2013·Science·Florian KleinMichel C Nussenzweig

❮ Previous
Next ❯

Citations

May 8, 2013·Behavioural Brain Research·Magdalena M SauvageZachery Beer
Apr 9, 2015·Frontiers in Immunology·José Esparza
Jul 30, 2014·Frontiers in Immunology·José Esparza, Marc H V Van Regenmortel
May 21, 2016·Journal of the International AIDS Society·Kathleen M MacQueen, Mitchell Warren
Jun 14, 2016·Journal of the International AIDS Society
Sep 23, 2016·International Journal of Molecular Sciences·Marc H V Van Regenmortel
Jun 30, 2019·Bioinformatics·Syed Faraz AhmedMatthew R McKay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

California State Journal of Medicine
Journal of the American Optometric Association
F D Smith
Advances in Experimental Medicine and Biology
A M Schultz
© 2021 Meta ULC. All rights reserved